Efficacy and Safety of GP40071 Compared to NovoRapid® Penfill® in Type 1 Diabetes Mellitus Patients
Status:
Completed
Trial end date:
2020-01-21
Target enrollment:
Participant gender:
Summary
This trial is a multi-center, open-label, randomized, parallel group trial in adult patients
with T1DM comparing the efficacy and safety of GP40071 (insulin aspart, GEROPHARM) with that
of NovoRapid®.